Efficacy of epsilon-aminocaproic acid in children undergoing cardiac surgery

G D Williams1, S L Bratton, E C Riley

  • 1Department of Anesthesiology, University of Washington School of Medicine, Seattle, USA.

Insights

Epsilon-aminocaproic acid (EACA) reduced intraoperative blood loss in pediatric cardiac surgery patients but did not significantly decrease blood product transfusions. Further studies are needed to explore optimal dosing for efficacy.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Pediatric Surgery

Background:

  • Bleeding is a significant complication in pediatric cardiac surgery.
  • Prophylactic antifibrinolytic agents like epsilon-aminocaproic acid (EACA) are used to reduce blood loss.
  • Optimal EACA dosing in pediatric cardiac surgery remains under investigation.

Purpose of the Study:

  • To compare coagulation test results, blood loss, and blood product transfusions between children receiving prophylactic EACA and a control group.
  • To evaluate the efficacy of EACA in reducing bleeding complications during pediatric cardiac surgery.

Main Methods:

  • A nested case-control study was conducted at a pediatric medical center.
  • 70 patients receiving prophylactic EACA were matched with 70 control patients.
  • EACA was administered intravenously (load and infusion) to patients at increased risk for bleeding.

Main Results:

  • The EACA group showed significantly less intraoperative blood loss (p = 0.02).
  • No significant differences were observed in postoperative chest tube output between groups.
  • Fewer patients in the EACA group required reexploration for bleeding (p < 0.05), and coagulation parameters were better preserved.

Conclusions:

  • EACA effectively reduced intraoperative blood loss in pediatric cardiac surgery.
  • EACA did not significantly decrease blood product transfusions, possibly due to underdosing.
  • Further research is warranted to determine optimal EACA dosing strategies for improved efficacy.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...